Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation
about
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsCD1d- and MR1-Restricted T Cells in SepsisTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsThe regulatory role of invariant NKT cells in tumor immunityThe CD1 size problem: lipid antigens, ligands, and scaffoldsThe actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.Structural Evaluation of Potent NKT Cell Agonists: Implications for Design of Novel Stimulatory LigandsMechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT CellsA Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T CellsGalactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.Human and Mouse Type I Natural Killer T Cell Antigen Receptors Exhibit Different Fine Specificities for CD1d-Antigen ComplexNKT TCR Recognition of CD1d- -C-GalactosylceramideStructural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363Glycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T CellsStructural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory PropertiesEnhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor ProtectionRecognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptorIntravital imaging - dynamic insights into natural killer T cell biologyAn in silico approach for modelling T-helper polarizing iNKT cell agonistsImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsRaising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.Linking inflammation to natural killer T cell activation.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsThe stimulating adventure of KRN 7000.A rapid fluorescence-based assay for classification of iNKT cell activating glycolipids.Cytokine dependent and independent iNKT cell activationThe effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunityiNKT cell autoreactivity: what is 'self' and how is it recognized?Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathwayFine tuning by human CD1e of lipid-specific immune responses.Simplexide induces CD1d-dependent cytokine and chemokine production from human monocytesDiscovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system.The split personality of NKT cells in malignancy, autoimmune and allergic disordersInvariant natural killer T cells recognize lipid self antigen induced by microbial danger signalsSpecies Specific Differences of CD1d Oligomer Loading In Vitro.Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.
P2860
Q26748456-45194359-BFCA-464D-A862-2724D0847352Q26796132-F3EABAC3-3212-45DA-ADBD-2B62BF7CDDECQ26825059-74263448-1611-426C-91AC-0F8EFDBF57B0Q27023425-37683189-2D82-4EBC-A073-D19E18040AE7Q27024188-3DE89695-0865-45F3-83CC-5C3F2C9B651AQ27319157-6D6CCB69-24C7-4C5C-BDF8-376E67764E3DQ27657337-A440E3FC-ECE2-4FFA-971C-696DECFB3E3FQ27658388-34093DB3-5597-4751-903B-BF330E6752BFQ27667168-714DE5D4-6739-4BBB-B26B-8EAF58873E52Q27667759-7283A39B-C9DE-464D-832E-F228DBBC9B4BQ27673493-370B7F65-CE84-42A4-A601-3EFDE46BBF61Q27674653-2E8E7BF9-DE5D-4B4B-A0E0-A52787573C5FQ27675769-DC7B2A00-E962-40A1-A487-3049B928A3DAQ27676395-84E46A5F-B026-495A-B5D6-5F006551439AQ27677017-E7E63998-8D63-4B6C-9DC0-82BFA321B07CQ27679771-B7915422-AEED-4F09-943E-3D901294627EQ27681807-07051C1E-03C5-4333-BF24-29AEF4774AA6Q28081530-7875D6D1-DF4E-4648-AF92-5791104BDE69Q28539366-326271C2-5FF8-495E-B7B6-726764ED32E8Q28543248-36099ECB-A50B-4E6E-B15D-3F2FD35E1E1FQ30408873-8FE0C702-ABE7-4943-BF76-384DC958B45EQ33512902-84DFE281-49C1-4157-9F3E-79C9FECF843CQ33720359-8DC5CBD6-FA99-4078-846B-B2265407F33AQ33724575-EC7D19F3-E207-4B93-9532-AE3BDE6D5AD2Q33778356-1C29D122-C6CA-4BA5-9A70-0983B9E5FB91Q33843406-0A0A6043-ED0A-4493-BFB4-B4181202C7AEQ33852300-32B864BC-C3B6-433D-9143-48DE3F8C4C06Q34039891-A1D80323-719E-4DBA-B97B-E14EC5B8A8F5Q34179888-49F5BAB2-EBED-4DE8-888F-AA1DFF23B8EFQ34519826-437594D0-65CE-4BE8-94A5-D37FEFED5DB4Q34626935-FE8A4ACA-EE80-4912-A266-2226C2408FC6Q34760309-3BA5ECD9-797F-415E-8B89-DA5A4ED5B197Q35148930-D1480C31-727C-43CA-AFFC-E7FC62900056Q35180802-1D95F943-3498-4B89-B194-72CA81A56784Q35414072-FBDB3770-EF7B-41DE-82C2-07DAF84FE691Q35585671-55CB15D9-683C-435B-BFDC-1BCCA7CFB9F5Q35590727-4D54822A-23BE-4160-8DD5-221F74F53DF9Q35622939-ACEF2164-4ED9-4B34-B108-12B08702DC03Q35850396-B9241FCB-9F4B-47C0-922D-35143338E346Q35850748-8432E7E5-33D5-4BCA-AA1B-27580338A97A
P2860
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinetics and cellular site of ...... tural killer T cell activation
@en
Kinetics and cellular site of ...... ural killer T cell activation.
@nl
type
label
Kinetics and cellular site of ...... tural killer T cell activation
@en
Kinetics and cellular site of ...... ural killer T cell activation.
@nl
prefLabel
Kinetics and cellular site of ...... tural killer T cell activation
@en
Kinetics and cellular site of ...... ural killer T cell activation.
@nl
P2093
P2860
P50
P1433
P1476
Kinetics and cellular site of ...... tural killer T cell activation
@en
P2093
Alberto Molano
Andres Baena
Elliot S Jerud
Gabriel Bricard
Karl O A Yu
Manjunatha M Venkataswamy
Michael F Goldberg
Peter Cresswell
Petr A Illarionov
P2860
P304
P356
10.1016/J.IMMUNI.2009.03.022
P407
P577
2009-06-01T00:00:00Z